These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 16313259
1. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies. Graf M, Reif S, Hecht K, Kroell T, Nuessler V, Schmetzer H. Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259 [Abstract] [Full Text] [Related]
2. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H. Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246 [Abstract] [Full Text] [Related]
3. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML). Graf M, Reif S, Hecht K, Pelka-Fleischer R, Kroell T, Pfister K, Schmetzer H. Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672 [Abstract] [Full Text] [Related]
4. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis. Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H. Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776 [Abstract] [Full Text] [Related]
5. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis. Graf M, Reif S, Kröll T, Hecht K, Nuessler V, Schmetzer H. Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517 [Abstract] [Full Text] [Related]
6. Detailed analysis of FLT3 expression levels in acute myeloid leukemia. Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S. Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434 [Abstract] [Full Text] [Related]
7. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M. Neoplasma; 1993 Dec; 40(5):275-81. PubMed ID: 8272155 [Abstract] [Full Text] [Related]
8. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category. Ghannadan M, Wimazal F, Simonitsch I, Sperr WR, Mayerhofer M, Sillaber C, Hauswirth AW, Gadner H, Chott A, Horny HP, Lechner K, Valent P. Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284 [Abstract] [Full Text] [Related]
9. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M. Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721 [Abstract] [Full Text] [Related]
10. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia. Moshaver B, van Rhenen A, Kelder A, van der Pol M, Terwijn M, Bachas C, Westra AH, Ossenkoppele GJ, Zweegman S, Schuurhuis GJ. Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043 [Abstract] [Full Text] [Related]
11. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma. Hentschel N, Krusch M, Kiener PA, Kolb HJ, Salih HR, Schmetzer HM. Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841 [Abstract] [Full Text] [Related]
12. Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia. Maynadié M, Gerland L, Aho S, Girodon F, Bernier M, Brunet C, Campos L, Daliphard S, Deneys V, Falkenrodt A, Jacob MC, Kühlein E, LeCalvez G, Moskovtchenko P, Philip P, Carli PM, Faure GC, Béné MC, GEIL. Haematologica; 2002 Aug; 87(8):795-803. PubMed ID: 12161354 [Abstract] [Full Text] [Related]
13. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry. Rezaei A, Adib M, Mokarian F, Tebianian M, Nassiri R. Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032 [Abstract] [Full Text] [Related]
14. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience. Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X. Cancer; 2008 Feb 01; 112(3):572-80. PubMed ID: 18085638 [Abstract] [Full Text] [Related]
15. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia. Auewarakul CU, Lauhakirti D, Promsuwicha O, Munkhetvit C. Ann Hematol; 2006 Feb 01; 85(2):108-12. PubMed ID: 16320053 [Abstract] [Full Text] [Related]
16. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles. Oyan AM, Bø TH, Jonassen I, Ulvestad E, Gjertsen BT, Kalland KH, Bruserud O. Cytometry B Clin Cytom; 2005 Mar 01; 64(1):18-27. PubMed ID: 15668952 [Abstract] [Full Text] [Related]
17. Podocalyxin is expressed in normal and leukemic monocytes. Riccioni R, Calzolari A, Biffoni M, Senese M, Riti V, Petrucci E, Pasquini L, Cedrone M, Lo-Coco F, Diverio D, Foà R, Peschle C, Testa U. Blood Cells Mol Dis; 2006 Mar 01; 37(3):218-25. PubMed ID: 17059890 [Abstract] [Full Text] [Related]
18. Prognostic significance of CD56 antigen expression in acute myeloid leukemia. Di Bona E, Sartori R, Zambello R, Guercini N, Madeo D, Rodeghiero F. Haematologica; 2002 Mar 01; 87(3):250-6. PubMed ID: 11869936 [Abstract] [Full Text] [Related]
19. Diagnosis of acute myeloid leukemia and system Coulter VCS. Bruno A, Del Poeta G, Venditti A, Stasi R, Adorno G, Aronica G, Suppo G, Di Rienzo AM, Iazzoni R, Tribalto M. Haematologica; 1994 Mar 01; 79(5):420-8. PubMed ID: 7843628 [Abstract] [Full Text] [Related]
20. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia. Monreal MB, Pardo ML, Pavlovsky MA, Fernandez I, Corrado CS, Giere I, Sapia S, Pavlovsky S. Cytometry B Clin Cytom; 2006 Mar 01; 70(2):63-70. PubMed ID: 16470534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]